title: Inhibition of the specific binding of human lactotransferrin to human peripheral-blood phytohaemagglutinin-stimulated lymphocytes by fluorescein labelling and location of the binding site.
abstract: Labelling of human lactotransferrin with fluorescein 5'-isothiocyanate (FITC) in an equimolar ratio inhibits the binding of the protein to phytohaemagglutinin-activated human peripheral-blood lymphocytes. Therefore it can be assumed that FITC reacts at, or near, the receptor-binding site. Three FITC-labelled peptides have been purified from a tryptic digest of the FITC-labelled lactotransferrin. The determination of their amino acid sequence and their localization on the primary structure of the protein permitted the identification of two FITC-accessible areas in the N-terminal lobe and one in the C-terminal lobe. In fact, only 10% of the total FITC was conjugated to one lysine residue (Lys579) of the C-terminal lobe, whereas most (80%) of the FITC was conjugated to three close lysine residues [Lys263 (65% of total fluorescence), Lys280 and Lys282 (15% of total fluorescence)] located in beta-turn structures, of the N-terminal domain I of human lactotransferrin. The results obtained show that the receptor-binding site should be located in the vicinity of the FITC-accessible Lys263, Lys280 and Lys282, and corroborate our preliminary results reporting the involvement of the N-terminal domain I in the binding of human lactotransferrin to mitogen-stimulated lymphocytes [Rochard, Legrand, Mazurier, Montreuil & Spik (1989) FEBS Lett. 255, 201-204]. In any case, FITC labelling is not suitable for studying the binding of lactotransferrin to activated lymphocytes and its use may lead to erroneous interpretations of cell binding experiments.
authors.affiliation: Université des Sciences et Techniques de Lille Flandres-Artois (Unité Mixte de Recherche n. 111 du C.N.R.S.), Villeneuve d'Ascq, France.
authors.forename: D
authors.initials: D
authors.lastname: Legrand
authors.forename: J
authors.initials: J
authors.lastname: Mazurier
authors.forename: P
authors.initials: P
authors.lastname: Maes
authors.forename: E
authors.initials: E
authors.lastname: Rochard
authors.forename: J
authors.initials: J
authors.lastname: Montreuil
authors.forename: G
authors.initials: G
authors.lastname: Spik
mesh_terms: D000595:Amino Acid Sequence; D001667:Binding, Competitive; D002851:Chromatography, High Pressure Liquid; D016650:Fluorescein-5-isothiocyanate; D005452:Fluoresceins; D006801:Humans; D007781:Lactoferrin / Q000378:metabolism*; D008214:Lymphocytes / Q000378:metabolism*; D008969:Molecular Sequence Data; D010835:Phytohemagglutinins / Q000494:pharmacology*; D011956:Receptors, Cell Surface / Q000037:antagonists & inhibitors* / Q000737:chemistry; D013861:Thiocyanates
chemical_list: D005452:Fluoresceins; D010835:Phytohemagglutinins; D011956:Receptors, Cell Surface; D013861:Thiocyanates; C038340:lactoferrin receptors; D007781:Lactoferrin; D016650:Fluorescein-5-isothiocyanate